SEC 13F Intelligence

Marshall Wace, LLP / MRK

Marshall Wace, LLP’s Merck & Co Inc Position

Does Marshall Wace, LLP own Merck & Co Inc (MRK)? Yes2.78M shares worth $334M (+0.33% of its 13F portfolio) as of Q1 2026, down from 3.97M shares the prior filed quarter.

Position Value
$334M
Q1 2026
Shares
2.78M
% of Portfolio
+0.33%
Quarters Held
27
currently held

Position History MRK

Reported value by quarter
Q4 ’18: $10MQ4 ’18Q1 ’19: $37MQ2 ’19: $39MQ3 ’19: $17MQ4 ’19: $32MQ4 ’19Q1 ’20: $25MQ2 ’20: $13MQ3 ’20: $22MQ4 ’20: $4MQ4 ’20Q3 ’21: $189,000Q4 ’21: $3MQ1 ’22: $557MQ2 ’22: $529MQ2 ’22Q3 ’22: $57MQ4 ’22: $115MQ2 ’23: $20MQ3 ’23: $211MQ3 ’23Q4 ’23: $435MQ1 ’24: $257MQ2 ’24: $320MQ3 ’24: $381,561Q3 ’24Q4 ’24: $32,927Q1 ’25: $682,804Q2 ’25: $249MQ3 ’25: $74MQ3 ’25Q4 ’25: $418MQ1 ’26: $334Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.78M$334M+0.33%
Q4 20253.97M$418M+0.38%
Q3 2025883.9K$74M+0.08%
Q2 20253.14M$249M+0.28%
Q1 20257.6K$682,8040.00%
Q4 2024331$32,9270.00%
Q3 20243.4K$381,5610.00%
Q2 20242.58M$320M+0.43%
Q1 20241.95M$257M+0.39%
Q4 20233.99M$435M+0.74%
Q3 20232.05M$211M+0.43%
Q2 2023176.1K$20M+0.04%
Q4 20221.03M$115M+0.26%
Q3 2022661.3K$57M+0.12%
Q2 20225.80M$529M+1.09%
Q1 20226.79M$557M+1.05%
Q4 202139.1K$3M+0.01%
Q3 20212.5K$189,0000.00%
Q4 202054.1K$4M+0.02%
Q3 2020261.0K$22M+0.14%
Q2 2020163.6K$13M+0.09%
Q1 2020321.8K$25M+0.25%
Q4 2019354.6K$32M+0.22%
Q3 2019206.6K$17M+0.14%
Q2 2019464.3K$39M+0.32%
Q1 2019440.2K$37M+0.17%
Q4 2018134.0K$10M+0.10%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Marshall Wace, LLP’s full portfolio or all institutional holders of MRK.